Elsevier sells its local author books portfolio in Brazil to GEN

Elsevier also licenses the translation and distribution of certain Elsevier titles in Portuguese to GEN

Amsterdam, August 5, 2019

Elsevier, a global information analytics business specializing in science and health, part of RELX, has sold its Portuguese-language books portfolio in Brazil to Grupo Editorial Nacional (GEN). Elsevier also signed an agreement to license the translation and distribution of certain Elsevier titles in Portuguese to GEN. Elsevier’s Science, Technology and Medicine (STM) portfolio in Brazil of over 1,000 titles spans several disciplines and includes both locally authored content and local editions of Elsevier’s flagship titles such as Netter, Guyton, Cecil, Sabiston, Potter and Krause.

GEN is a leading STM Publisher in Brazil. In addition to being one of the founders of the Minha Biblioteca – e-book rental platform for educational institutions – GEN has been investing heavily in online education as well as online resources for students and universities. By adding the Elsevier Brazil titles to its portfolio, GEN completes its twelfth publishing acquisition in 12 years of existence.

With the sale of this portfolio to GEN, Elsevier Brazil will increase its focus on the electronic solutions which are driving its strategy of combining content with technology to produce knowledge that assists customers in their decision-making process. The recently announced Order Sets and Care Planning products, which are now in the process of being integrated with leading Brazilian electronic health records (EHR) solutions, are notable examples of this strategy.


About Grupo Editorial Nacional (GEN)
GEN | Grupo Editorial Nacional, a holding company founded in 2007, is a leader in the segment of scientific, technical and professional publications and content in Brazil. GEN aggregates some of the most respected publishers in the Medical and Health, Technical and Physical Sciences, Legal, Humanities and Social Sciences, Business and Management areas. GEN brings together a catalogue of approximately 4,500 titles, most of them also available in digital version or as apps. In addition to providing content for academic and professional development, GEN has business units specializing in providing services to the pharmaceutical industry and on-site and distance learning.

About Elsevier
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com

Media contact
Aluisio Affonso, Director of Marketing
+55 (21) 3543-0826

Christopher Capot, Global Communications
+1 (212) 633 3164